Posted September 4, 2020
(OMNS August 26, 2020) This observational study was conducted to assess the impact of intravenous megadose vitamin C on the quality of life (QoL) of terminal cancer outpatients experiencing side effects of cancer therapies (radiotherapy, chemotherapy, surgery and/or hormonotherapy). Read more.